Cover Image

Comparison of the effectiveness and renal safety of tenofovir versus entecavir in patients with chronic hepatitis B

Objective: To compare the effectiveness and renal safety of treatment with tenofovir versus entecavir in patients with chronic hepatitis-B. Methods: Retrospective study in hepatitis-B patients who initiated treatment with tenofovir or entecavir since January 1998 until 2013. The primary effectivenes...

Full description

Saved in:

Bibliographic Details
Main Authors:	Beatriz López Centeno (Author), Roberto Collado Borrell (Author), Montserrat Pérez Encinas (Author), Maria Luisa Gutiérrez García (Author), Patricia Sanmartin Fenollera (Author)
Format:	Book
Published:	Elsevier, 2016-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Renal safety of tenofovir and/or entecavir in patients with chronic HBV monoinfection
by: Yang YM, et al.
Published: (2017)

Cost-effectiveness of switching from tenofovir disoproxil fumarate to tenofovir alafenamide versus entecavir for chronic hepatitis B patients in Greece
by: Emmanouil Sinakos, et al.
Published: (2024)

Comparative effectiveness of tenofovir versus entecavir in patients with hepatitis B virus-related cirrhosis in Taiwan: a retrospective cohort study
by: Yu-Han Huang, et al.
Published: (2023)

Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a reconstructed individual patient data meta-analysis
by: Jian-Xin Peng, et al.
Published: (2024)

Virologic breakthrough in a patient with chronic hepatitis B by combination treatment with tenofovir disoproxil fumarate and entecavir
by: Suzuki F, et al.
Published: (2014)

Resultados en la práctica clínica del tratamiento de la hepatitis crónica por virus B con tenofovir y entecavir
by: Diana Horta, et al.

Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores
by: Yan Huang, et al.
Published: (2022)

Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?
by: Andrew Hill, et al.
Published: (2018)

A systematic review and meta-analysis comparing the impact of tenofovir and entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma patients undergoing liver resection
by: Lingbo Hu, et al.
Published: (2024)

Clinical utility of entecavir for chronic hepatitis B in Chinese patients
by: Wang JY
Published: (2013)

Entecavir Treatment in Children and Adolescents with Chronic Hepatitis B Virus Infection
by: Kai-Chi Chang, et al.
Published: (2016)

Effectiveness and safety of tenofovir amibufenamide and its comparison with tenofovir alafenamide in patients with chronic hepatitis B: results from a retrospective real-world study
by: Lanqing Li, et al.
Published: (2023)

Constipation during Entecavir treatment in Chronic Hepatitis B patients: Two Cases Reports
by: Meng-Lan Wang, et al.
Published: (2017)

Effects of Fuzheng Huayu recipe on entecavir pharmacokinetics in normal and dimethylnitrosamine-induced hepatic fibrosis rats
by: Tao Yang, et al.
Published: (2020)

Cost-effectiveness of entecavir versus adefovir for the treatment of chronic hepatitis B in patients with decompensated cirrhosis from a third-party US payer perspective
by: Tsai N, et al.
Published: (2012)

Tenofovir and its potential in the treatment of hepatitis B virus
by: Laura Reynaud, et al.
Published: (2009)

Analysis of minimum target prices for production of entecavir to treat hepatitis B in high- and low-income countries
by: Andrew Hill, et al.
Published: (2015)

Cost-effectiveness analysis of lamivudine, telbivudine, and entecavir in treatment of chronic hepatitis B with adefovir dipivoxil resistance
by: Wang G, et al.
Published: (2015)

Non-Inferior Efficacy of Tenofovir Disoproxil to Tenofovir Disoproxil Fumarate in Virologically Suppressed Chronic Hepatitis B Patients
by: Yim HJ, et al.
Published: (2022)

An overview of tenofovir and renal disease for the HIV-treating clinician
by: Willem D.F. Venter, et al.
Published: (2018)

Is increasing the dose of Entecavir effective in partial virological responders?
by: Erturk A, et al.
Published: (2014)

Entecavir: A Review and Considerations for Its Application in Oncology
by: Tânia Lourenço, et al.
Published: (2023)

The efficacy of pegylated interferon alpha-2a and entecavir in HBeAg-positive children and adolescents with chronic hepatitis B
by: Yi He, et al.
Published: (2022)

Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population
by: Aida N. Kawuma, et al.
Published: (2023)

Validated spectrometric determination of penciclovir and entecavir in bulk and in pharmaceutical preparations
by: Asmaa A. Elzaher, et al.
Published: (2016)

Renal effects of non-tenofovir antiretroviral therapy in patients living with HIV
by: Milena M McLaughlin, et al.
Published: (2018)

Tenofovir alafenamide in the treatment of chronic hepatitis B: design, development, and place in therapy
by: Ogawa E, et al.
Published: (2017)

Low-dose prednisone plus entecavir in the treatment of hepatitis B virus associated glomerulonephritis with massive proteinuria: a report of 3 cases
by: Yuan-yuan Liu, et al.
Published: (2024)

HBV-Associated Cryoglobulinemic Vasculitis: Remission after Antiviral Therapy with Entecavir
by: Mauro Viganò, et al.
Published: (2014)

Treatment of Blue Rubber Bled Nevus syndrome with subcutaneous octreotide: a case report
by: Beatriz López Centeno, et al.
Published: (2015)

Urine Assay to Measure Tenofovir Concentrations in Patients Taking Tenofovir Alafenamide
by: Linden Lalley-Chareczko, et al.
Published: (2020)

The effects of the insulin resistance index on the virologic response to entecavir in patients with HBeAg-positive chronic hepatitis B and nonalcoholic fatty liver disease
by: Zhu LY, et al.
Published: (2016)

Concomitant food intake does not affect the efficacy of entecavir in chronic hepatitis B patients with virological response: a randomized, multicenter, noninferiority trial
by: Cho EJ, et al.
Published: (2018)

Anti-phospholipase A2 receptor antibody positive hepatitis B virus-associated membranous nephropathy remitted with entecavir after relapse with lamivudine
by: Yosuke Sasaki, et al.
Published: (2018)

Associations between plasma tenofovir concentration and renal function markers in HIV-infected women
by: Mwila Mulubwa, et al.
Published: (2016)

Real-world impact of switching from tenofovir disoproxil fumarate to tenofovir alafenamide
by: Sarah M Michienzi, et al.
Published: (2021)

Tenofovir disoproxil fumarate for preventing mother-to-child transmission of hepatitis B: a literature review
by: Iulia Baciu, et al.
Published: (2021)

Long-Term Effects of Tenofovir on Liver Histopathology in Patients with Chronic Viral Hepatitis B Infection
by: Bengü TATAR, et al.
Published: (2020)

Immunological outcomes between Tenofovir versus Zidovudine-based regimens: a retrospective cohort study
by: Meshack Lugoba1, et al.
Published: (2019)

First-In-Human Study on Pharmacokinetics, Safety, and Tolerability of Single and Multiple Escalating Doses of Hepenofovir, a Novel Hepatic Targeting Prodrug of Tenofovir in Healthy Chinese Subjects
by: Hong Zhang, et al.
Published: (2022)